Global 3d Bioprinting Market Forecast 2023-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	236 Pages	Inkwood Research	April, 2023	INKR17870483

Best Price Guarantee
Price	from $2,900
Length	236 Pages
Publisher	Inkwood Research
Published Date	April, 2023
SKU	INKR17870483

Global 3d Bioprinting Market Forecast 2023-2032

KEY FINDINGS

The global 3D bioprinting market is predicted to record a CAGR of 16.69% during the forecast period, 2023-2032. The market growth is attributed to the high prevalence of chronic disease, the growing focus on regenerative medicine, R&D investments and technological advancements, and the increasing elderly population.

MARKET INSIGHTS

3D bioprinting is an additive manufacturing process that uses biomaterials and cells like nutrients and living cells instead of traditional plastics and metals to create artificial structures that mimic natural human tissues.

The growing elderly population is a key growth driver of the global 3D bioprinting market growth. The aging population is increasingly vulnerable to bone injuries, obesity, and osteoporosis, which further contributes to the failure of orthopedic implants. In this regard, 3D bioprinted bone can be personalized to patient-specific needs.

As per the Oncology Nursing Society, around 60% of all cancers in the US occur in the older population. Such aspects raise the need for a better understanding of the drugs required for the treatment. In addition, researchers can get a better idea about how tumors react to certain drugs through 3D bioprinting tumors. Accordingly, 3D bioprinted tumors can be used to experiment with new drugs and treatments. As a result, such factors are expected to propel growth opportunities for 3D bioprinting. However, the global 3D bioprinting market growth is restrained by a lack of skilled professionals and high costs.

REGIONAL INSIGHTS

The global 3D bioprinting market growth assessment includes the geographical evaluation of North America, Europe, Asia-Pacific, and Rest of World. North America is the largest revenue-generating region in the global market, accredited to the huge geriatric population and high prevalence of cardiovascular diseases.

COMPETITIVE INSIGHTS

Prominent market leaders are investing in merger & acquisition activities and product innovations to maintain a competitive edge in the market. Some of the leading companies in the market are Advanced Solutions Life Sciences, Cyfuse Biomedical KK, GeSiM GmbH, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology: 1.1. Study Objectives; 1.2. Methodology; 1.3. Assumptions & Limitations
2. Executive Summary: 2.1. Market Size & Estimates; 2.2. Market Overview; 2.3. Scope Of Study; 2.4. Crisis Scenario Analysis; 2.4.1. Impact Of Covid-19 On 3d Bioprinting Market; 2.5. Major Market Findings; 2.5.1. Emergence Of 4d Bioprinting As A Substitute For 3d Bioprinting; 2.5.2. Personalized Medicine Likely To Boost 3d Bioprinting; 2.5.3. Rising Interest In The Application Of Bioprinting Against The Sars-cov-2 Virus
3. Market Dynamics: 3.1. Key Drivers; 3.1.1. Surging Geriatric Population; 3.1.2. Technological Advancements And R&D Investments; 3.1.3. Rising Focus On Regenerative Medicine; 3.1.4. High Prevalence Of Chronic Conditions; 3.2. Key Restraints; 3.2.1. Operational Challenges During Manufacturing; 3.2.2. Exorbitant Costs Of 3d Bioprinters; 3.2.3. Lack Of Trained Professionals
4. Key Analytics: 4.1. Parent Market Analysis; 4.2. Key Market Trends; 4.3. Porter’s Five Forces Analysis; 4.3.1. Buyers Power; 4.3.2. Suppliers Power; 4.3.3. Substitution; 4.3.4. New Entrants; 4.3.5. Industry Rivalry; 4.4. Growth Prospect Mapping; 4.4.1. Growth Prospect Mapping In United States; 4.4.2. Growth Prospect Mapping In Germany; 4.4.3. Growth Prospect Mapping In China; 4.4.4. Growth Prospect Mapping For Brazil; 4.5. Market Maturity Analysis; 4.6. Market Concentration Analysis; 4.7. Value Chain Analysis; 4.7.1. Design & Software Providers; 4.7.2. Prototype Production; 4.7.3. Distribution; 4.7.4. End-users
5. Market By Component: 5.1. 3d Bioprinter; 5.2. Bioink
6. Market By Biomaterial: 6.1. Hydrogel; 6.2. Living Cells; 6.3. Extracellular Matrices; 6.4. Other Biomaterials
7. Market By Technology: 7.1. Magnetic Levitation Bioprinting; 7.2. Inkjet-based Bioprinting; 7.3. Syringe/Extrusion-based Bioprinting; 7.4. Laser-assisted Bioprinting; 7.5. Other Technologies
8. Market By Application: 8.1. Drug Testing & Development; 8.2. Tissue Engineering & Regenerative Medicine; 8.3. Food Testing; 8.4. Research; 8.5. Other Applications
9. Market By End-user: 9.1. Hospitals; 9.2. Biopharmaceuticals Companies; 9.3. Research Organizations And Academic Institutes; 9.4. Other End-users
10. Geographical Analysis: 10.1. North America; 10.1.1. Market Size & Estimates; 10.1.2. North America 3d Bioprinting Market Drivers; 10.1.3. North America 3d Bioprinting Market Challenges; 10.1.4. North America 3d Bioprinting Market Regulatory Framework; 10.1.5. Key Players In North America 3d Bioprinting Market; 10.1.6. Country Analysis; 10.1.6.1. United States; 10.1.6.1.1. United States 3d Bioprinting Market Size & Opportunities; 10.1.6.2. Canada; 10.1.6.2.1. Canada 3d Bioprinting Market Size & Opportunities; 10.2. Europe; 10.2.1. Market Size & Estimates; 10.2.2. Europe 3d Bioprinting Market Drivers; 10.2.3. Europe 3d Bioprinting Market Challenges; 10.2.4. Europe 3d Bioprinting Market Regulatory Framework; 10.2.5. Key Players In Europe 3d Bioprinting Market; 10.2.6. Country Analysis; 10.2.6.1. United Kingdom; 10.2.6.1.1. United Kingdom 3d Bioprinting Market Size & Opportunities; 10.2.6.2. Germany; 10.2.6.2.1. Germany 3d Bioprinting Market Size & Opportunities; 10.2.6.3. France; 10.2.6.3.1. France 3d Bioprinting Market Size & Opportunities; 10.2.6.4. Italy; 10.2.6.4.1. Italy 3d Bioprinting Market Size & Opportunities; 10.2.6.5. Spain; 10.2.6.5.1. Spain 3d Bioprinting Market Size & Opportunities; 10.2.6.6. Nordic Countries; 10.2.6.6.1. Nordic Countries 3d Bioprinting Market Size & Opportunities; 10.2.6.7. Rest Of Europe; 10.2.6.7.1. Rest Of Europe 3d Bioprinting Market Size & Opportunities; 10.3. Asia-pacific; 10.3.1. Market Size & Estimates; 10.3.2. Asia-pacific 3d Bioprinting Market Drivers; 10.3.3. Asia-pacific 3d Bioprinting Market Challenges; 10.3.4. Asia-pacific 3d Bioprinting Market Regulatory Framework; 10.3.5. Key Players In Asia-pacific 3d Bioprinting Market; 10.3.6. Country Analysis; 10.3.6.1. China; 10.3.6.1.1. China 3d Bioprinting Market Size & Opportunities; 10.3.6.2. Japan; 10.3.6.2.1. Japan 3d Bioprinting Market Size & Opportunities; 10.3.6.3. India; 10.3.6.3.1. India 3d Bioprinting Market Size & Opportunities; 10.3.6.4. South Korea; 10.3.6.4.1. South Korea 3d Bioprinting Market Size & Opportunities; 10.3.6.5. Singapore; 10.3.6.5.1. Singapore 3d Bioprinting Market Size & Opportunities; 10.3.6.6. Thailand; 10.3.6.6.1. Thailand 3d Bioprinting Market Size & Opportunities; 10.3.6.7. Australia & New Zealand; 10.3.6.7.1. Australia & New Zealand 3d Bioprinting Market Size & Opportunities; 10.3.6.8. Rest Of Asia-pacific; 10.3.6.8.1. Rest Of Asia-pacific 3d Bioprinting Market Size & Opportunities; 10.4. Rest Of World; 10.4.1. Market Size & Estimates; 10.4.2. Rest Of World 3d Bioprinting Market Drivers; 10.4.3. Rest Of World 3d Bioprinting Market Challenges; 10.4.4. Key Players In Rest Of World 3d Bioprinting Market; 10.4.5. Regional Analysis; 10.4.5.1. Latin America; 10.4.5.1.1. Latin America 3d Bioprinting Market Size & Opportunities; 10.4.5.2. Middle East & Africa; 10.4.5.2.1. Middle East & Africa 3d Bioprinting Market Size & Opportunities
11. Competitive Landscape: 11.1. Key Strategic Developments; 11.1.1. Mergers & Acquisitions; 11.1.2. Product Launches & Developments; 11.1.3. Partnerships & Agreements; 11.2. Company Profiles; 11.2.1. 3d Bioprinting Solutions; 11.2.1.1. Company Overview; 11.2.1.2. Products List; 11.2.2. Advanced Solutions Life Sciences; 11.2.2.1. Company Overview; 11.2.2.2. Products List; 11.2.3. Allevi; 11.2.3.1. Company Overview; 11.2.3.2. Products List; 11.2.4. Cellink; 11.2.4.1. Company Overview; 11.2.4.2. Products List; 11.2.4.3. Strengths & Challenges; 11.2.5. Collplant Biotechnologies Ltd; 11.2.5.1. Company Overview; 11.2.5.2. Products List; 11.2.6. Cyfuse Biomedical Kk; 11.2.6.1. Company Overview; 11.2.6.2. Products List; 11.2.6.3. Strengths & Challenges; 11.2.7. Envisiontec Ṁ Inc; 11.2.7.1. Company Overview; 11.2.7.2. Products List; 11.2.7.3. Strengths & Challenges; 11.2.8. Gesim Gmbh; 11.2.8.1. Company Overview; 11.2.8.2. Products List; 11.2.8.3. Strengths & Challenges; 11.2.9. Inventia Life Science Pty Ltd; 11.2.9.1. Company Overview; 11.2.9.2. Products List; 11.2.10. Organovo Holdings Inc; 11.2.10.1. Company Overview; 11.2.10.2. Products List; 11.2.10.3. Strengths & Challenges; 11.2.11. Regemat 3d; 11.2.11.1. Company Overview; 11.2.11.2. Products List; 11.2.11.3. Strengths & Challenges; 11.2.12. Regenhu; 11.2.12.1. Company Overview; 11.2.12.2. Products List; 11.2.12.3. Strengths & Challenges; 11.2.13. Revotek Co Ltd; 11.2.13.1. Company Overview; 11.2.13.2. Products List; 11.2.14. Rokit Healthcare Inc; 11.2.14.1. Company Overview; 11.2.14.2. Products List; 11.2.15. Stratasys Ltd; 11.2.15.1. Company Overview; 11.2.15.2. Products List